Eddy Saad

Also affiliated with Oklahoma State University Oklahoma City

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes”.

Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes

Cancer Cell(2024)10.1016/j.ccell.2024.03.002

N/A

0.578DataRank · unranked

46 citations

Chris Labaki, Tejas Jammihal, Wanling Xie, Maxine Sun, Valisha Shah +19 more

Targeting of HIF2-driven cachexia in kidney cancer

Nature Medicine(2025)10.1038/s41591-025-04054-2

N/A

0.419DataRank · unranked

9 citations

Laura Stransky, Nikita Bhalerao, Nitin H. Shirole, Qinqin Jiang, Eddy Saad +15 more

Myeloid cells mediate interferon-driven resistance to immunotherapy in advanced renal cell carcinoma

Immunity(2025)10.1016/j.immuni.2025.10.013

N/A

0.330DataRank · unranked

8 citations

Soki Kashima, Sabrina Y. Camp, Kevin Meli, Eddy Saad, Breanna Titchen +14 more

The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs

Nature Communications(2025)10.1038/s41467-025-64983-x

N/A

0.269DataRank · unranked

5 citations

Pooneh Koochaki, Sayed Matar, Fatme Ghandour, Marc Machaalani, Eddy Saad +22 more

Immune Spatial Organization Predicts Metastasis Risk in Aggressive Localized Prostate Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.15.654324

N/A

0.104DataRank · unranked

1 citations

Anwar Abdelnaser, Jeremiah A. Wala, Alexander J Haas, Alfred A. Barney, Eddy Saad +12 more

Integrative clinical, genomic, and transcriptomic characterization of circulating KIM-1 in metastatic RCC.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.4546

N/A

0.104DataRank · unranked

1 citations

Renée Maria Saliby, Eddy Saad, Clara Steiner, Caiwei Zhong, Emre Yekedüz +15 more

Targeting AXL can effectively overcome c-Met-induced therapeutic resistance in renal cancer and promote tumor cell death through increased oxidative stress

Cancer Letters(2025)10.1016/j.canlet.2025.217984

N/A

0DataRank · unranked

3 citations

Marc Machaalani, Laxminarayan Rawat, Johannes Wedel, Saba Tabasum, Yuzuru Sasamoto +14 more

HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy

Cell(2025)10.1016/j.cell.2025.01.046

N/A

0DataRank · unranked

56 citations

David A. Braun, Karl R. Clauser, Vijyendra Ramesh, Nitin H. Shirole, Joseph E. Duke-Cohan +41 more

HIF2-driven PTHrP Causes Cachexia and Hypercalcemia in Kidney Cancer: Treatment with HIF2 Inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.09.675147

N/A

0DataRank · unranked

1 citations

Laura Stransky, Nikita Bhalerao, Nitin H. Shirole, Qinqin Jiang, Eddy Saad +15 more

Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection

The Lancet Regional Health - Americas(2025)10.1016/j.lana.2025.101038

N/A

0DataRank · unranked

0 citations

Chih–Yuan Hsu, Sanjay Mishra, Elizabeth A. Griffiths, Brahm H. Segal, Clara Hwang +30 more

Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma

Cell Reports(2024)10.1016/j.celrep.2024.114350

N/A

0DataRank · unranked

29 citations

Karl Semaan, Marc Eid, Ji-Heui Seo, Simon Garinet, Matthew P. Davidsohn +34 more